Principal Scientist, Oncology @ Celltech Ltd (now UCB Pharma)
Mark Rolfe's Education
Columbia University Vagelos College of Physicians and Surgeons
Visiting Fellow (DNA damage response)
1988 - 1989
Imperial Cancer Research Fund
Post-Doctoral Fellow (cancer drug resistance)
1985 - 1988
Medical Research Council, National Institute for Medical Research
Ph.D. (Molecular genetics)
1982 - 1985
University of Oxford
BA, MA (Biochemistry)
1978 - 1982
Mark Rolfe's Skills
Biotechnology
Cancer
Oncology
Drug Discovery
Biomarker Discovery
Antibodies
Therapists
Clinical Development
Immunology
Lifesciences
Mark Rolfe's Summary
Mark Rolfe, based in California, United States, is currently a Senior Vice President at Bristol-Myers Squibb, bringing experience from previous roles at Celgene, Cleave Biosciences, CytomX Therapeutics and Facet Biotech. Mark Rolfe holds a 1988 - 1989 Visiting Fellow in DNA damage response @ Columbia University Vagelos College of Physicians and Surgeons. With a robust skill set that includes Biotechnology, Cancer, Oncology, Drug Discovery, Biomarker Discovery and more, Mark Rolfe contributes valuable insights to the industry. Mark Rolfe has 5 emails and 1 mobile phone number on RocketReach.